Navigation Links
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
Date:12/10/2008

ves of women with advanced breast cancer.

"Researching new cancer treatments is a complex step by step process. Each success helps lay the foundation for the next step forward," said William M. Burns, CEO Division Roche Pharmaceuticals. "These results show that we are making significant progress towards giving doctors and their breast cancer

patients better and more effective treatment options to fight this devastating disease at all stages," he added.

    Presentation of Data

    Herceptin

    Gianni L et al  Neoadjuvant trastuzumab in patients with   Friday 12th,
                    HER2-positive locally advanced breast      December
                    cancer: primary efficacy analysis of the   09:30 hrs
                    NOAH trial                                 General
                                                               Session 3
                                                               (Hall D)

    Xeloda

    Joensuu H et    Significant improvement in                 Sunday 14th,
    al. for The     recurrence-free survival (RFS)             December
    Finnish Breast  when capecitabine (X) is                   11:45 hrs
    Cancer Group    integrated into docetaxel (T)              General
                    5-FU + epirubicin + cyclophosphamide       Session 7
                    (CEF) adjuvant therapy for high-risk
                    early breast cancer (BC): interim
                    analysis of the FinXX-trial.

    Avastin

    Smith IE et al  Primary analysis of study MO19391, an      Saturday
                    open-label safety study of bevacizumab     13th,
                    plus taxane-based therapy as 1st-line      December
                    treatment of patients with locally         07:00 hrs
                    recurrent or metastatic breast cancer.     Poster
                                                               Session 4

'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
6. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)...  IsoRay, Inc. (AMEX: ISR ), ( ... an exclusive international distribution agreement with IASIS Medical for ... Greece . IsoRay is a medical technology ... applications for brain cancer, lung cancer, head and neck ... IASIS Medical is ideally suited to support IsoRay,s ...
(Date:5/21/2013)... , May 21, 2013  The North Shore-LIJ ... used to measure hand-washing compliance at North Shore University ... introducing cameras in operating rooms at Forest ... http://photos.prnewswire.com/prnh/20130521/NY17810 ) The new pilot program strengthens ... their operating rooms (ORs), the first time in the ...
(Date:5/21/2013)... NEW YORK , May 21, 2013 ... market research report is available in its ... Global Markets and Technologies for Optical Coherence ...   STUDY OBJECTIVES ... conducting this study is to offer synopsis ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19
... China, Feb. 25, 2011 /PRNewswire-Asia/ -- Tongjitang Chinese Medicines ... ), announced that it has called an extraordinary general ... 10:00 a.m. (China time) on Thursday, March 31, 2011, ... Nanshan Medical Device Park, 1019 Nanhai Avenue, Nanshan District, ...
... Inc. (OTC Bulletin Board: HASC ), ... in Alabama, Florida, and Mississippi, today announced it has ... products available for immediate delivery. The ... for patients throughout the United States to order medical ...
Cached Medicine Technology:Tongjitang Chinese Medicines Company Announces Extraordinary General Meeting of Shareholders 2Tongjitang Chinese Medicines Company Announces Extraordinary General Meeting of Shareholders 3HASCO Medical Expands Online Offering 2
(Date:5/21/2013)... May 21, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices, is addressing ... Joint Surgery on May 15, 2013. The study found ... identify complications that occur in patients with metal-on-metal hip ... ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve known ...
(Date:5/21/2013)... Beach, CA (PRWEB) May 21, 2013 ... 3rd Annual EB-5 Investment Summit: Dealmakers Conference in ... Dealmakers Conference will focus on exploring alternative finance ... provide the latest market, legal and economic information, ... immigration and legal professionals within the EB-5 industry. ...
(Date:5/21/2013)... 21, 2013 Arizona State University ... want to develop their ideas into solutions, products ... , The university is recruiting participants for AREA48 ... space” that provides early-stage entrepreneurs with opportunities to ... open to anyone, ASU is particularly seeking participation ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... on cable networks and cable channels across the country, ... on its YouTube channel. The producers of the series ... in the shipping industry, the manufacturing industry, health-related companies, ... medical facilities and medical practitioners in all parts of ...
(Date:5/21/2013)... Angeles, CA (PRWEB) May 21, 2013 ... sports organization, and Bodybuilding.com, the largest online retailer of ... you a new reality-based sports show, Warrior Island. ... vote on; YouTube, Facebook & Twitter, with our unique ... Warrior Island maroons these elite fighters on an island ...
Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3
... - Nearly 75 percent have or want to have a wellness ... percent want taxpayer-funded universal ... health ... one of the nation,s leading employee benefits advisory,organizations, today announced key ...
... Cancer Society highlights that long-term favorable trends have stalled ... cancer death rates in the U.S. The report, Cancer ... points out that drops in smoking appear to have ... or slightly declining since 2000 after increasing for more ...
... Attorneys for the Service,Employees International Union claimed in ... and other acts of intimidation against,officers, directors and ... is nothing more than "free speech.", A ... County,Superior Court Commission Jon Rantzman remains in effect ...
... of being diagnosed with late-stage breast cancer , , MONDAY, April ... regular mammograms reduce the risk of being diagnosed with late-stage ... in this age group have regular screenings, a new study ... the Journal of Clinical Oncology . , Women aged ...
... Endorses Competition in the Durable Medical ... Equipment Marketplace, ... jury verdict for its clients today in a business,litigation case involving ... relationship or expectancy. The case,was MP Medical, Inc. v. Philip Wegman, ...
... Red Cross Partners With 3M Corporation and Roush Fenway ... April 21 The American Red Cross,today announced the ... to,recruit NASCAR fans as blood donors and raise awareness ... in America needs blood., (Photo: http://www.newscom.com/cgi-bin/prnh/20080421/DC20034 ...
Cached Medicine News:Health News:Survey: Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 2Health News:Survey: Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 3Health News:American Cancer Society report details cancer prevention efforts 2Health News:American Cancer Society report details cancer prevention efforts 3Health News:American Cancer Society report details cancer prevention efforts 4Health News:SEIU Claims Right of 'Free Speech' to Stalk, Harass, and Threaten Registered Nurses According to the California Nurses Association 2Health News:Mammograms Still a Good Idea for Elderly Women 2Health News:American Red Cross Launches National Campaign to Connect NASCAR Fans With Blood Donations 2Health News:American Red Cross Launches National Campaign to Connect NASCAR Fans With Blood Donations 3
Ocuvite® Lutein is an advanced antioxidant supplement formulated to provide nutritional support for the eye....
Expert QC data management solution...
The AVOXimeter 1000E measures:, Oxygen saturation (for diagnosing shunts) , Oxygen content (for Fick Principle calculations), Total hemoglobin concentration , ,Ideal for adult and pediatri...
Inquire...
Medicine Products: